More Life Company Corp. (MVMDF)
Sector: Biotechnology
Industry: Biotechnology
More Life Company Corp.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 0.0321 | 0.0321 | 0.0300 | 0.0300 | 5,033 |
| Oct 23, 2026 | 0.0285 | 0.0290 | 0.0285 | 0.0290 | 22,086 |
| Oct 22, 2026 | 0.0354 | 0.0363 | 0.0270 | 0.0270 | 1,069,698 |
| Oct 19, 2026 | 0.0334 | 0.0334 | 0.0334 | 0.0334 | 2,610 |
| Oct 16, 2026 | 0.0346 | 0.0353 | 0.0346 | 0.0353 | 129,737 |
| Oct 15, 2026 | 0.0390 | 0.0390 | 0.0335 | 0.0335 | 206,461 |
| Oct 14, 2026 | 0.0350 | 0.0384 | 0.0350 | 0.0371 | 125,000 |
| Oct 12, 2026 | 0.0488 | 0.0488 | 0.0405 | 0.0405 | 138,213 |
| Oct 9, 2026 | 0.0422 | 0.0433 | 0.0414 | 0.0414 | 97,000 |
| Oct 8, 2026 | 0.0460 | 0.0460 | 0.0458 | 0.0458 | 60,036 |
| Oct 7, 2026 | 0.0453 | 0.0473 | 0.0451 | 0.0451 | 190,000 |
| Oct 6, 2026 | 0.0422 | 0.0440 | 0.0422 | 0.0423 | 94,659 |
| Oct 5, 2026 | 0.0438 | 0.0444 | 0.0438 | 0.0441 | 8,049 |
More Life Company Corp., operating through its subsidiary More Life, is a company focused on the health and wellness industry.
The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors.
Its portfolio includes Quicksome, an advanced oral drug formulation and delivery system; Quicksol, a technology designed to improve solubility; and a dose-sparing adjuvant. Currently, the company is also progressing with the development of IM032, a treatment being tested in male beagle dogs to assess the differences between intramuscular and subcutaneous administration routes. More Life is headquartered in Concord, Canada.
based on 352.26M shares outstanding
30d Avg
--
60d Avg
--
90d Avg
40.00K